National Bank of Canada
PBYI icon

National Bank of Canada’s Puma Biotechnology PBYI Stock Holding History

National Bank of Canada’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$154 Buy
+19
New +$139 ﹤0.01% 2984
2026
Q1 		– Sell
-10
Closed -$59 – 3149
2025
Q4 		$59 Buy
+10
New +$53 ﹤0.01% 2809

Other funds holding PBYI

ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

National Bank of Canada's PBYI Position: Q2 2026 in Review

National Bank of Canada opened a new position in Puma Biotechnology (PBYI) in Q2 2026: 19 shares worth $154. The stake represents ﹤0.01% of the portfolio and ranks #2984 among its holdings. This is a return to the name: National Bank of Canada previously reported a position in PBYI as recently as Q4 2025.

National Bank of Canada first reported a position in PBYI in Q4 2025 and has held it in 2 quarters since. 160 funds tracked by Wall St. Rank hold PBYI as of Q2 2026.

  • National Bank of Canada held 19 shares of Puma Biotechnology worth $154 as of Q2 2026.
  • Puma Biotechnology was a new National Bank of Canada position in Q2 2026.
  • Puma Biotechnology made up ﹤0.01% of National Bank of Canada's portfolio in Q2 2026, its #2984 holding.
  • National Bank of Canada first reported a position in Puma Biotechnology in Q4 2025 and has held it in 2 quarters since.
  • 160 funds tracked by Wall St. Rank held Puma Biotechnology as of Q2 2026.

Based on National Bank of Canada's 13F filing for Q2 2026, filed 10 Aug 2026.